BST/60Q (BST/60Q)

Stuttgart Stock Exchange: BST/60Q · EUR

€12.7

-0.06 (-0.5%)· Recorded snapshot

Market cap	79.2M
Revenue (ttm)	466.6K
Net income (ttm)	-10.3M
EPS (ttm)	-€1.76

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 466.6K
Net income (ttm): -10.3M
EPS (ttm): -€1.76
Market cap: 79.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-80.6

P25 n/aP50 n/aP75 n/a

ROIC-50.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BST/60Q indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

PLN

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Poland
Country code	DE
Earnings date	2026-11-19
Employees	82
Employees change	-9
Employees growth	-9.89%
Enterprise value	EUR 63.6M
Exchange	Stuttgart Stock Exchange
Financial currency	PLN
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2015
Industry	Biotechnology
Is primary listing	No
ISIN number	PLCPTRT00014
Last refreshed	2026-10-28
Market cap	EUR 79.2M
Next earnings date	2026-11-19
Price	EUR 12.68
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bst/60Q
Website	https://captortherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-13.89%
EV/Sales	139.56x
FCF / EV yield	-27.36%
FCF yield	-21.96%
P/B ratio	5.23x
P/S ratio	169.77x
Price / tangible book value	5.32x
Sector forward P/E	14.95x
Sector P/E	40.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	192.12%
Operating margin	-2,311.12%
Pretax margin	-2,206.28%
ROA	-43.06%
ROA (5Y)	-31.09%
ROCE	-70.55%
ROE	-80.62%
ROE (5Y)	-64.74%
ROIC	-50.85%
Tax / revenue	1.35%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	-27.67%
Gross profit growth 3Y	-24.79%
Net income growth years	0
Revenue growth	-81.93%
Revenue growth (Q)	-18.71%
Revenue growth (QoQ)	398.17%
Revenue growth 3Y	-43%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -84,443
Depreciation and amortization	EUR 820,064
EBIT	EUR -10.8M
EBITDA	EUR -9.9M
EPS	EUR -1.76
Financing cash flow	EUR 21.8M
Free cash flow	EUR -17.4M
Gross profit	EUR 896,539
Income taxes	EUR 6,281
Investing cash flow	EUR -7.5M
Net borrowing	EUR -702,880
Net cash flow	EUR -3M
Net income	EUR -10.3M
Operating income	EUR -10.8M
Revenue	EUR 466,647

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	9.26
Book value per share	EUR 2.38
Debt / equity	0.04
Interest coverage	-178.31
Long-term assets	EUR 1.5M
Long-term liabilities	EUR 227,799
Net cash (debt)	EUR 16M
Net cash / market cap	20.21%
Net cash growth	45.58%
Net debt / equity	-1.06
Piotroski F-Score	2
Property, plant and equipment	EUR 835,734
Shareholders' equity	EUR 15.1M
Tangible book value	EUR 14.9M
Tangible book value per share	EUR 2.35
Total assets	EUR 18.5M
Total cash	EUR 16.6M
Total debt	EUR 618,784
Total liabilities	EUR 3.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.03
Current assets	EUR 17M
Current liabilities	EUR 3.1M
Current ratio	5.41
Net working capital	EUR -2M
Quick ratio	5.41
Working capital	EUR 14.2M
Working capital turnover	0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-12.34%
Shareholder yield	-12.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 17.07
1D price change	-0.47%
1M price change	-21.73%
1M total return	-21.73%
1W price change	-2.61%
1W total return	-2.61%
1Y price change	21.34%
1Y return CAGR	21.36%
1Y total return	21.34%
20-day SMA	EUR 14.01
200-day SMA	EUR 17.56
3M price change	-27.21%
3M total return	-27.21%
3Y price change	-40.47%
3Y return CAGR	-15.87%
3Y total return	-40.47%
50-day SMA	EUR 15.47
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 20.90
52-week high date	2026-03-10
52-week low	EUR 9.88
52-week low date	2025-11-12
5Y price change	-67.97%
5Y return CAGR	-20.36%
5Y total return	-67.97%
6M price change	-32.62%
6M total return	-32.62%
All-time high	EUR 42.54
All-time high date	2021-06-29
All-time low	EUR 6.96
All-time low date	2025-06-04
Average true range (ATR)	EUR 0.45
Average volume	0
Change from 52-week high	-39.33%
Change from 52-week low	28.34%
Change from all-time high	-70.19%
Change from all-time low	82.18%
Change from open	-0.47%
Day's gap	0%
High price	EUR 12.74
Low price	EUR 12.62
Monthly RSI	40.66
Open price	EUR 12.74
Position in 52-week range	50%
Previous close	EUR 12.74
Price vs 150-day SMA	-25.73%
Price vs 20-day SMA	-9.5%
Price vs 200-day SMA	-27.79%
Price vs 50-day SMA	-18.03%
RSI	19.91
Sharpe ratio	0.47
Sharpe ratio (3Y)	-0.22
Sharpe ratio (5Y)	-0.37
Sortino ratio	1.02
Sortino ratio (3Y)	-0.21
Sortino ratio (5Y)	-0.42
Weekly RSI	27.6
YTD price change	-20.75%
YTD total return	-20.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.5M
Shares change (QoQ)	12.37%
Shares change (YoY)	12.34%
Shares held by insiders	25.97%
Shares held by institutions	34.95%

Deeper analysis on BST/60Q

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BST/60Q report

Is a complete BST/60Q research report available?

No complete published report is available for bst/60Q (BST/60Q) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/60Q (BST/60Q)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/60Q

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BST/60Q indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/60Q

Frequently asked questions